NDC 66993-429

Tafluprost Ophthalmic

Tafluprost

Tafluprost Ophthalmic is a Ophthalmic Solution/ Drops in the Human Prescription Drug category. It is labeled and distributed by Prasco Laboratories. The primary component is Tafluprost.

Product ID66993-429_c8695339-0d5e-4988-b411-f094676b77bf
NDC66993-429
Product TypeHuman Prescription Drug
Proprietary NameTafluprost Ophthalmic
Generic NameTafluprost
Dosage FormSolution/ Drops
Route of AdministrationOPHTHALMIC
Marketing Start Date2022-11-18
Marketing CategoryNDA AUTHORIZED GENERIC /
Application NumberNDA202514
Labeler NamePrasco Laboratories
Substance NameTAFLUPROST
Active Ingredient Strength0 mg/.3mL
Pharm ClassesIncreased Prostaglandin Activity [PE], Prostaglandin Analog [EPC], Prostaglandin Receptor Agonists [MoA], Prostaglandins [CS]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 66993-429-30

3 POUCH in 1 CARTON (66993-429-30) > 10 VIAL, SINGLE-USE in 1 POUCH (66993-429-81) > .3 mL in 1 VIAL, SINGLE-USE
Marketing Start Date2022-11-18
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Tafluprost Ophthalmic" or generic name "Tafluprost"

NDCBrand NameGeneric Name
66993-429Tafluprost Ophthalmictafluprost
17478-609ZIOPTANtafluprost
82584-609ZIOPTANTafluprost

© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.